Capital Building in Washington DC

Advocacy

To improve patient care, ASCO advocates for increased federal funding for research, greater health care access, value in cancer care, and payment reform.

  • ASCO Supports Withdrawal from Most Favored Nation Model

    The Association for Clinical Oncology (ASCO) commends the Biden Administration for proposing to rescind the Most Favored Nation (MFN) model from consideration. ASCO has consistently opposed the ill-advised MFN model, as it would have had a devastating impact on people with cancer.

    Read Now
  • PracticeNET Data Projects Sequestration Cuts on Cancer Care

    ASCO released an in-depth analysis of the impact the 2022 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules—as well as pending sequestration cuts—could have on cancer care beginning January 1, 2022.

    Learn More
  • Final FY 2022 Hospital Inpatient Payment Proposal

    The Centers for Medicare & Medicaid Services (CMS) released updates to the Inpatient Prospective Payment System (IPPS) for fiscal year (FY) 2022 final rule, including updates to Medicare payment policies and payment rates for most acute care hospitals.

    Read More

Random Quote

"I value the broad exposure ASCO affords my specialty throughout the oncology world. All of us have the opportunity to learn about the latest advances in our field and to broadly share our own research."
Clifford Hudis, MD, FASCO
ASCO CEO